Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Judi Ford"'
Autor:
Luc Desnoyers, Yuanhui Huang, Andrew Jang, Elizabeth Menendez, Jason Gary Sagert, Shouchun Liu, Eric Brecht, Olga Vasiljeva, Margaret Nguyen, Nicole Lapuyade, James W. West, Michael Krimm, Annie Yang Weaver, Jeanne Grace Flandez, Stephen R. Moore, Judi Ford, W. Michael Kavanaugh, Linnea Diep, Tereza Sputova, Jonathan A. Terrett, Shweta Singh, Amy DuPage, Jennifer Richardson
Publikováno v:
Molecular Cancer Therapeutics. 14:C165-C165
Antibody drug conjugates (ADCs) have shown their greatest clinical utility when targeting antigens expressed at very high levels on cancer cells that have coincidentally lower expression in normal tissues. This is exemplified by the approvals of tras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dfa74c2d7feb91893fa08e253ae6595
https://doi.org/10.1158/1535-7163.targ-15-c165
https://doi.org/10.1158/1535-7163.targ-15-c165
Autor:
Krishna Plou, Olga Vasiljeva, Henry B. Lowman, Shouchun Liu, Jennifer Richardson, James W. West, Jason Gary Sagert, Luc Desnoyers, Elizabeth Menendez, Judi Ford
Publikováno v:
Cancer Research. 74:2664-2664
Probodies represent a unique class of antibody therapeutics that specifically target therapeutic activity to diseased tissues, such as cancer. A Probody is a fully recombinant protein that contains a masking peptide that blocks the antibody's antigen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f92740ce6aeba12356c17a014a2cd641
https://doi.org/10.1158/1538-7445.am2014-2664
https://doi.org/10.1158/1538-7445.am2014-2664